Trial intelligence / Profile preview

Huaier Granule in COVID-19

NCT04291053Phase 3Unknown

Sponsor
Tongji Hospital
Start
Apr 2020
Primary completion
Aug 2020
Modality
Small Molecules
01

Overview

A Phase 3 trial of huaier granule in coronavirus disease 2019 (COVID-19), sponsored by Tongji Hospital. Status: unknown.

02

Drugs

huaier granule
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on NCT04291053.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04291053.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call